FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gabriella Ferrandina

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Gabriella Ferrandina; Marco Petrillo; A Pietragalla; Vanda Salutari; C Conte; Rosa I De Vincenzo; Mariagrazia Distefano; M L Scarciglia; Giovanni Scambia
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
Giovanna Mantegna; Marco Petrillo; Giovanni Scambia; Serena Terzano; Laura Venditti; Luigi Pedone Anchora; Gilda Fuoco; Gabriella Ferrandina
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.
Silvia Prislei; Giuseppina Raspaglio; Giovanni Scambia; Shohreh Shahabi; Steven Sieber; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Ferlini Cristiano
MiR-200c and HuR in ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gabriella Ferrandina (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gabriella Ferrandina; Marco Petrillo; A Pietragalla; Vanda Salutari; C Conte; Rosa I De Vincenzo; Mariagrazia Distefano; M L Scarciglia; Giovanni Scambia
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
Gynecologic oncology 2013;128(3):518-23.
2013: Giovanna Mantegna; Marco Petrillo; Giovanni Scambia; Serena Terzano; Laura Venditti; Luigi Pedone Anchora; Gilda Fuoco; Gabriella Ferrandina
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.
BMC cancer 2013;13():127.
2013: Silvia Prislei; Giuseppina Raspaglio; Giovanni Scambia; Shohreh Shahabi; Steven Sieber; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Ferlini Cristiano
MiR-200c and HuR in ovarian cancer.
BMC cancer 2013;13():72.
2013: Francesco Legge; Alessandro Lucidi; Gabriella Macchia; Pasquale A Margariti; Alessio Giuseppe Morganti; Marco Petrillo; Giovanni Scambia; Vito Carone; Vito Iannone; Gabriella Ferrandina
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures.
Acta oncologica (Stockholm, Sweden) 2013;52(1):166-73.
2012: Mariangela Massaccesi; Fabio Pacelli; G D A Padula; Giuseppina Sallustio; V Valentini; L Caravatta; Numa Cellini; M Ciuffreda; G Corrado; E Cucci; R De Vizia; Francesco Deodato; Cinzia Digesù; Gabriella Ferrandina; Gabriella Macchia; A G Morganti
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful?
The British journal of radiology 2012;85(1017):e682-5.
2012: Luciana Caravatta; Numa Cellini; Francesco Deodato; Gabriella Ferrandina; Mariano Flocco; Gabriella Macchia; Mariangela Massaccesi; Samantha Mignogna; Fabio Pacelli; Gilbert D A Padula; Marco Rossi; Giovanni Scambia; Andrea Scapati; Rosa Tambaro; Vincenzo Valentini; Pierluigi Bonomo; Alessio G Morganti
Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
International journal of radiation oncology, biology, physics 2012;83(5):e627-31.
2012: Gabriella Macchia; Mariangela Massaccesi; Alessio Giuseppe Morganti; Giovanni Scambia; Vincenzo Valentini; Numa Cellini; SAVINO CILLA; Francesco Deodato; Alessandro Lucidi; Gabriella Ferrandina
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1).
Gynecologic oncology 2012;125(3):594-9.
2012: Marco Petrillo; Giovanni Scambia; Gabriella Ferrandina
Novel targets for VEGF-independent anti-angiogenic drugs.
Expert opinion on investigational drugs 2012;21(4):451-72.
2012: Gabriella Ferrandina; A Lucidi; Gabriella Macchia; A G Morganti; Amelia Paglia; G Corrado; Francesco Fanfani; L Tagliaferri; V Valentini; Giovanni Scambia
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2012;38(3):238-44.
2012: Gabriella Ferrandina; Gilda Fuoco; Domenica Lorusso; Giovanna Mantegna; Andrea Marcellusi; Cristina Moruzzi; Marco Petrillo; Serena Terzano; Laura Venditti; Giovanni Scambia
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study.
Gynecologic oncology 2012;124(3):389-94.
2012: Marta De Donato; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Lella Petrella; Giovanni Scambia; Shohreh Shahabi; Valerio Gaetano Vellone; Gian Franco Zannoni; Ferlini Cristiano
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.
Journal of cellular physiology 2012;227(3):1034-41.
2012: Maddalena Borriello; Arnaldo Carbone; Vito Iannone; Alessandro Lucidi; Gabriella Ferrandina
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report.
Diagnostic pathology 2012;7():116.
2012: Cinzia Baranello; Mara Fanelli; Mirko Andreoli; Gabriella Ferrandina; Marisa Mariani; Enrica Martinelli; Giovanni Scambia; Shohreh Shahabi; Ferlini Cristiano
Adrenomedullin in ovarian cancer: foe in vitro and friend in vivo?
PloS one 2012;7(7):e40678.
2012: Gabriella Ferrandina; Marisa Mariani; Giovanni Scambia; Shohreh Shahabi; Mirko Andreoli; Ferlini Cristiano
Novel drugs targeting microtubules: the role of epothilones.
Current pharmaceutical design 2012;18(19):2793-803.
2012: Daniela Gallo; Maria Grazia Prisco; Giovanni Scambia; Ilaria De Stefano; Gabriella Ferrandina
Estrogen receptor beta in cancer: an attractive target for therapy.
Current pharmaceutical design 2012;18(19):2734-57.
2012: Marco Petrillo; Maddalena Borriello; Gilda Fuoco; Vito Iannone; Francesco Legge; Gabriella Ferrandina
Novel VEGF-independent strategies targeting tumor vasculature: clinical aspects.
Current pharmaceutical design 2012;18(19):2702-12.
2012: Gabriella Ferrandina
Targeting molecular pathways in human malignancy: current status and future development.
Current pharmaceutical design 2012;18(19):2671.
2011: giorgia mangili; Paolo Scollo; Cristina Sigismondi; Saverio Tateo; Massimo Candiani; Gennaro Cormio; Gabriella Ferrandina; Angiolo Gadducci; Stefano Greggi; Domenica Lorusso
Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(8):1414-21.
2011: Sandro Pignata; Carmela Pisano; Alberto Ravaioli; Vanda Salutari; Antonella Savarese; Laura Scaltriti; Giovanni Scambia; Paolo Scollo; Roberto Sorio; Stefano Tamberi; Maria Rosaria Valerio; Enrico Aitini; Alba Brandes; Enrico Breda; Pietro Del Medico; Massimo Di Maio; Antonio Febbraro; Gabriella Ferrandina; Antonella Ferro; Luigi Frigerio; Ciro Gallo; Vittorio Gebbia; Stefano Greggi; Francesco Legge; Alessandra Vernaglia Lombardi; Domenica Lorusso; Alessandro Morabito; Pietro Musso; Donato Natale; Francesco Perrone
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(27):3628-35.
2011: Francesco Saverio Mennini; Donatella Panatto; Marco Petrillo; Cristina Ricci; Tiziana Sasso; Giovanni Scambia; Nausica Trivellizzi; Alessandro Capone; Paolo Cristoforoni; Rosa De Vincenzo; Elisa Di Capua; Gabriella Ferrandina; Andrea Marcellusi; Roberto Gasparini
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy.
Clinical therapeutics 2011;33(8):1084-1095.e4.
2011: Florence Joly; Karin Boman; Tiziana Dell'Anna; Mark Donoghoe; Michel Fabbro; Gabriella Ferrandina; Jens Huober; ISABELLE RAY COQUARD; Alexander Reinthaller; Akira Sugimoto; Michelle Vaughan; Ignace Vergote; Eric Pujade-Lauraine
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.
Gynecologic oncology 2011;122(2):226-32.
2011: Antonia Carla Testa; Dirk Timmerman; Caroline Van Holsbeke; Valerio Gaetano Vellone; Gian Franco Zannoni; S Fransis; A Licameli; Manuela Ludovisi; F Mascilini; P Moerman; Giovanni Scambia; A Di Legge; Gabriella Ferrandina
Ovarian cancer arising in endometrioid cysts: ultrasound findings.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2011;38(1):99-106.
2011: Giacomo Corrado; Vanda Salutari; Gilda Fuoco; Alessandro Lucidi; Gabriella Ferrandina
Prolonged clinical response to trabectedin in a heavily pretreated patient with advanced uterine leiomyosarcoma: a case report and literature review.
Gynecologic oncology 2011;121(2):416-7.
2011: Laura Rosanò; Roberta Cianfrocca; Francesca Spinella; Valeriana Di Castro; Maria Rita Nicotra; Alessandro Lucidi; Gabriella Ferrandina; Pier Giorgio Natali; Anna Bagnato
Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(8):2350-60.
2011: Gabriella Macchia; Gabriella Ferrandina; Francesco Deodato; Romina Bibbò; Mariangela Massaccesi; Edy Ippolito; Numa Cellini; Giovanni Scambia; Vincenzo Valentini; Alessio Giuseppe Morganti
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1).
Gynecologic oncology 2011;120(3):485-8.
2011: Marco Petrillo; Gabriella Macchia; Arnaldo Carbone; Giacomo Corrado; Gabriella Ferrandina
Vulvar squamous cell carcinoma with sarcoma-like stroma: a case report and review of the literature.
Diagnostic pathology 2011;6():95.
2011: Francesco Legge; Amelia Paglia; Giovanni Scambia; Marco D'Asta; Gilda Fuoco; Gabriella Ferrandina
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients.
BMC cancer 2011;11():214.
2011: Alessio Giuseppe Morganti; SAVINO CILLA; Andrea De Gaetano; Simona Panunzi; Cinzia Digesù; Gabriella Macchia; Mariangela Massaccesi; Francesco Deodato; Gabriella Ferrandina; Numa Cellini; Giovanni Scambia; Angelo Piermattei; Vincenzo Valentini
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When?
Journal of applied clinical medical physics / American College of Medical Physics 2011;12(2):3451.
2010: Gabriella Ferrandina; Pasquale Alessandro Margariti; Daniela Smaniotto; Marco Petrillo; MG Salerno; Anna Fagotti; Gabriella Macchia; Alessio Morganti; Numa Cellini; Giovanni Scambia
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery.
Gynecologic oncology 2010;119(3):404-10.
2010: Gabriella Macchia; Gabriella Ferrandina; Francesco Legge; Francesco Deodato; Valeria Ruggieri; Domenica Lorusso; Gilbert D A Padula; Vincenzo Valentini; Numa Cellini; Giovanni Scambia; Alessio G Morganti
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1).
American journal of clinical oncology 2010;33(6):577-82.
2010: Gabriella Ferrandina; Andrea Marcellusi; Francesco Saverio Mennini; Marco Petrillo; Carlo Di Falco; Giovanni Scambia
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer.
Gynecologic oncology 2010;119(2):243-9.
2010: Francesco Legge; Gilda Fuoco; Domenica Lorusso; Alessandro Lucidi; Maddalena Borriello; Salvatore Pisconti; Giovanni Scambia; Gabriella Ferrandina
Pharmacotherapy of cervical cancer.
Expert opinion on pharmacotherapy 2010;11(12):2059-75.
2010: Gabriella Macchia; Gabriella Ferrandina; Francesco Deodato; Valeria Ruggieri; Mariangela Massaccesi; Vanda Salutari; Vincenzo Valentini; Numa Cellini; Giovanni Scambia; Alessio Giuseppe Morganti
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1).
Gynecologic oncology 2010;118(2):128-33.
2010: Giuseppina Raspaglio; Ilaria De Maria; Flavia Filippetti; Enrica Martinelli; Gian Franco Zannoni; Silvia Prislei; Gabriella Ferrandina; Shohreh Shahabi; Giovanni Scambia; Ferlini Cristiano
HuR regulates beta-tubulin isotype expression in ovarian cancer.
Cancer research 2010;70(14):5891-900.
2010: Mariangela Massaccesi; Luciana Caravatta; SAVINO CILLA; Cinzia Digesù; Francesco Deodato; Gabriella Macchia; Vincenzo Picardi; Adele Piscopo; Gilbert D A Padula; Gabriella Ferrandina; Giovanni Scambia; Vincenzo Valentini; Numa Cellini; Angelo Piermattei; Alessio Giuseppe Morganti
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study.
Tumori 2010;96(3):417-23.
2010: Giacomo Corrado; Salvatore Santaguida; Gianfranco Zannoni; Giovanni Scambia; Gabriella Ferrandina
Femur metastasis in carcinoma of the uterine cervix: a rare entity.
Archives of gynecology and obstetrics 2010;281(5):963-5.
2010: Alessandra Battaglia; Alexia Buzzonetti; Enrica Martinelli; Mara Fanelli; Marco Petrillo; Gabriella Ferrandina; Giovanni Scambia; Andrea Fattorossi
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer.
International journal of radiation oncology, biology, physics 2010;76(5):1546-53.
2010: Giovanni Almadori; Francesco Bussu; Marco Gessi; Gabriella Ferrandina; Giovanni Scambia; Libero Lauriola; Gaetano Paludetti; Franco O Ranelletti
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2010;46(6):1144-52.
2010: Gabriella Macchia; SAVINO CILLA; Gabriella Ferrandina; Gilbert D A Padula; Francesco Deodato; Cinzia Digesù; Luciana Caravatta; Vincenzo Picardi; Giacomo Corrado; Angelo Piermattei; Vincenzo Valentini; Numa Cellini; Giovanni Scambia; Alessio Giuseppe Morganti
Postoperative intensity-modulated radiotherapy in low-risk endometrial cancers: final results of a Phase I study.
International journal of radiation oncology, biology, physics 2010;76(5):1390-5.
2010: Ivan Mazzon; Giacomo Corrado; Valeria Masciullo; Daniela Morricone; Gabriella Ferrandina; Giovanni Scambia
Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.
Fertility and sterility 2010;93(4):1286-9.
2010: Gabriella Ferrandina; Valentina Mey; Sara Nannizzi; Simona Ricciardi; Marco Petrillo; Ferlini Cristiano; Romano Danesi; Giovanni Scambia; Mario Del Tacca
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.
Cancer chemotherapy and pharmacology 2010;65(4):679-86.
2010: Silvia Prislei; Marisa Mariani; Giuseppina Raspaglio; Simona Mozzetti; Flavia Filippetti; Gabriella Ferrandina; Giovanni Scambia; Ferlini Cristiano
RON and cisplatin resistance in ovarian cancer cell lines.
Oncology research 2010;19(1):13-22.
2010: Gabriella Ferrandina; Giacomo Corrado; Angelo Licameli; Domenica Lorusso; Gilda Fuoco; Salvatore Pisconti; Giovanni Scambia
Pegylated liposomal doxorubicin in the management of ovarian cancer.
Therapeutics and clinical risk management 2010;6():463-83.
2010: Giacomo Corrado; Giorgia Garganese; Gilda Fuoco; Arnaldo Carbone; Giovanni Scambia; Gabriella Ferrandina
Solitary pancreatic lymph node metastasis from carcinoma of the breast: case report.
Diagnostic pathology 2010;5():29.
2010: SAVINO CILLA; Gabriella Macchia; Cinzia Digesù; Francesco Deodato; Michele Romanella; Gabriella Ferrandina; Gilbert D A Padula; Vincenzo Picardi; Giovanni Scambia; Angelo Piermattei; Alessio Giuseppe Morganti
3D-Conformal versus intensity-modulated postoperative radiotherapy of vaginal vault: A dosimetric comparison.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2010;35(2):135-42.
2010: Anna Fagotti; Francesco Fanfani; G Vizzielli; Valerio Gallotta; Alfredo Ercoli; Amelia Paglia; Barbara Costantini; M Vigliotta; Giovanni Scambia; Gabriella Ferrandina
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
Gynecologic oncology 2010;116(1):72-7.
2010: Domenica Lorusso; Gabriella Ferrandina; Sandro Pignata; Manuela Ludovisi; R Viganò; S Scalone; P Scollo; Enrico Breda; A Pietragalla; Giovanni Scambia
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):61-6.
2009: Domenica Lorusso; Sara Mainenti; Antonella Pietragalla; Gabriella Ferrandina; Gilda Foco; Valeria Masciullo; Giovanni Scambia
Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity.
Expert opinion on investigational drugs 2009;18(12):1939-46.
2009: Antonia Carla Testa; Dirk Timmerman; Vanya MCA Van Belle; Erika Fruscella; Caroline Van Holsbeke; Luca Savelli; Enrico Ferrazzi; F P G Leone; H Marret; F Tranquart; Caterina Exacoustos; G Nazzaro; D Bokor; F Magri; Sabine Van Huffel; Gabriella Ferrandina; Lil Valentin
Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid components.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;34(6):699-710.
2009: Antonia Carla Testa; Manuela Ludovisi; Riccardo Manfredi; Gian Franco Zannoni; Benedetta Gui; D Basso; A Di Legge; A Licameli; R Di Bidino; Giovanni Scambia; Gabriella Ferrandina
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;34(3):335-44.
2009: Sandro Pignata; Gabriella Ferrandina; Giovanna Scarfone; Paolo Scollo; Franco Odicino; Gennaro Cormio; Dionyssios Katsaros; Luigi Frigerio; Liliana Mereu; Fabio Ghezzi; Luigi Manzione; Rossella Lauria; Enrico Breda; Desiderio Gueli Alletti; Michela Ballardini; Alessandra Vernaglia; Roberto Sorio; Salvatore Tumolo; Pietro Musso; Giovanna Magni; Claudio Pisano; Alessandro Morabito
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Critical reviews in oncology/hematology 2009;71(3):233-41.
2009: Alessandra Battaglia; Alexia Buzzonetti; Cinzia Baranello; Gabriella Ferrandina; Enrica Martinelli; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
Cancer immunology, immunotherapy : CII 2009;58(9):1363-73.
2009: Francesco Fanfani; Anna Fagotti; Gabriella Ferrandina; Francesco Raspagliesi; Antonino Ditto; Anna Maria Cerrotta; Alessio Giuseppe Morganti; Daniela Smaniotto; Giovanni Scambia
Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(6):1119-24.
2009: Francesco Deodato; Gabriella Macchia; Luca Grimaldi; Gabriella Ferrandina; Domenica Lorusso; Vanda Salutari; SAVINO CILLA; Vincenzo Valentini; Numa Cellini; Angelo Piermattei; Giovanni Scambia; Alessio Giuseppe Morganti
Stereotactic radiotherapy in recurrent gynecological cancer: a case series.
Oncology reports 2009;22(2):415-9.
2009: Gaetano Draisci; Luciano Frassanito; Raffaella Pinto; Bruno Zanfini; Gabriella Ferrandina; Alessio Valente
Safety and effectiveness of coadministration of intrathecal sufentanil and morphine in hyperbaric bupivacaine-based spinal anesthesia for cesarean section.
Journal of opioid management 2009;5(4):197-202.
2009: Gabriella Ferrandina; Marco Petrillo; Giuseppina Bonanno; Giovanni Scambia
Targeting CD133 antigen in cancer.
Expert opinion on therapeutic targets 2009;13(7):823-37.
2009: Sergio Rutella; Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Maria Corallo; Maria Grazia Prisco; Adriana Eramo; Chiara Napoletano; Daniela Gallo; Alessandro Perillo; Marianna Nuti; Luca Pierelli; Ugo Testa; Giovanni Scambia; Gabriella Ferrandina
Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4299-311.
2009: Fiorella Miceli; Franco O Ranelletti; Enrica Martinelli; Marco Petrillo; Giovanni Scambia; Pierluigi Navarra; Gabriella Ferrandina
Expression and subcellular localization of CRH and its receptors in human endometrial cancer.
Molecular and cellular endocrinology 2009;305(1-2):6-11.
2009: Rosa De Vincenzo; Giulia Amadio; Caterina Ricci; Angelo Licameli; Gabriella Ferrandina; Giovanni Capelli; Giovanni Scambia
Treatment of cervical cancer in Italy: strategies and their impact on the women.
Vaccine 2009;27 Suppl 1():A39-45.
2009: Antonia Carla Testa; Angelo Licameli; Alessia Di Legge; Floriana Mascilini; Lucio Petruzziello; Mauro Pelagalli; Giovanni Scambia; Gabriella Ferrandina
Color Doppler sonographic features of a Krukenberg tumor in pregnancy.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2009;28(5):695-8.
2009: Antonia Carla Testa; A Gaurilcikas; A Licameli; Carmine Di Stasi; D Lorusso; Giovanni Scambia; Gabriella Ferrandina
Sonographic imaging of urinoma.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(4):490-1.
2009: Gabriella Ferrandina; Enrica Martinelli; Marco Petrillo; Maria Grazia Prisco; Gianfranco Zannoni; Stefano Sioletic; Giovanni Scambia
CD133 antigen expression in ovarian cancer.
BMC cancer 2009;9():221.
2009: Antonia Carla Testa; A Gaurilcikas; A Licameli; R Mancari; A Di Legge; Marinella Malaggese; F Mascilini; Gian Franco Zannoni; Giovanni Scambia; Gabriella Ferrandina
Sonographic features of primary ovarian fibrosarcoma: a report of two cases.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2009;33(1):112-5.
2009: Alessio Giuseppe Morganti; SAVINO CILLA; Vincenzo Valentini; Cinzia Digesu'; Gabriella Macchia; Francesco Deodato; Gabriella Ferrandina; M Grazia Cece; Massimo Cirocco; Giorgia Garganese; Liberato Di Lullo; Divina Traficante; Francesca Scarabeo; Simona Panunzi; Andrea De Gaetano; Giuseppina Sallustio; Numa Cellini; Luigi Sofo; Angelo Piermattei; Giovanni Scambia
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):86-92.
2008: Gabriella Ferrandina; Enrica Martinelli; Marco Petrillo; Maria Grazia Prisco; Adriana Zucconi; Salvatore Santaguida; Gian Franco Zannoni; Giovanni Scambia; Ferlini Cristiano
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.
Gynecologic oncology 2008;111(2):237-43.
2008: Mariagrazia Distefano; Silvia Riccardi; Giovanni Capelli; Barbara Costantini; Marco Petrillo; Caterina Ricci; Giovanni Scambia; Gabriella Ferrandina
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy.
Gynecologic oncology 2008;111(1):144-50.
2008: Gabriella Ferrandina; Marco Petrillo; Gian Franco Zannoni; Antonia Testa; Stefano Sioletic; Giovanni Scambia
A case of isolated ovarian recurrence from vulvar carcinoma.
Archives of gynecology and obstetrics 2008;278(4):393-6.
2008: Gabriella Ferrandina; M Petrillo; A Carbone; Gian Franco Zannoni; Enrica Martinelli; M Prisco; Sandro Pignata; Enrico Breda; A Savarese; Giovanni Scambia
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
British journal of cancer 2008;98(12):1910-5.
2008: Michela Muscolini; Roberta Cianfrocca; Angela Sajeva; Simona Mozzetti; Gabriella Ferrandina; Antonio Costanzo; Loretta Tuosto
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells.
Molecular cancer therapeutics 2008;7(6):1410-9.
2008: Numa Cellini; Daniela Smaniotto; Giovanni Scambia; Stefano Luzi; Mario Balducci; Gabriella Ferrandina; Barbara Corvari; Pasquale A Margariti; Vincenzo Valentini; Giuseppe D'Agostino
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study.
American journal of clinical oncology 2008;31(3):280-4.
2008: Sandro Pignata; Enrico Breda; Giovanni Scambia; Carmela Pisano; Vittorina Zagonel; Domenica Lorusso; Stefano Greggi; Rocco De Vivo; Gabriella Ferrandina; Ciro Gallo; Francesco Perrone
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.
Critical reviews in oncology/hematology 2008;66(3):229-36.
2008: Luca Savelli; Michela Ceccarini; M Ludovisi; E Fruscella; Pierandrea De Iaco; Eugenio Salizzoni; M Mabrouk; Roberto Manfredi; Antonia Carla Testa; Gabriella Ferrandina
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2008;31(5):560-6.
2008: Gabriella Ferrandina; Manuela Ludovisi; Giacomo Corrado; Vito Carone; Marco Petrillo; Giovanni Scambia
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer.
Gynecologic oncology 2008;109(2):187-93.
2008: Gabriella Ferrandina; Giuseppina Bonanno; Luca Pierelli; Alessandro Perillo; Annabella Procoli; Andrea Mariotti; M Corallo; E Martinelli; Sergio Rutella; Amelia Paglia; Gian Franco Zannoni; Salvatore Mancuso; Giovanni Scambia
Expression of CD133-1 and CD133-2 in ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(3):506-14.
2008: Gabriella Ferrandina; Manuela Ludovisi; Domenica Lorusso; Sandro Pignata; Enrico Breda; Antonella Savarese; Pietro Del Medico; Laura Scaltriti; Dionyssios Katsaros; Domenico Priolo; Giovanni Scambia
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):890-6.
2008: Antonia Carla Testa; R Mancari; A Di Legge; F Mascilini; Vanda Salutari; Giovanni Scambia; Gabriella Ferrandina
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2008;31(2):218-21.
2008: Francesco Legge; Marco Petrillo; Vincenzo Adamo; Salvatore Pisconti; Giovanni Scambia; Gabriella Ferrandina
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.
BMC cancer 2008;8():367.
2008: Sandro Pignata; Gabriella Ferrandina; Giovanna Scarfone; Paolo Scollo; Franco Odicino; Gennaro Cormio; Dionyssios Katsaros; Antonella Villa; Liliana Mereu; Fabio Ghezzi; Luigi Manzione; Rossella Lauria; Enrico Breda; Desiderio Gueli Alletti; Michela Ballardini; Alessandra Vernaglia Lombardi; Roberto Sorio; Giorgia Mangili; Domenico Priolo; Giovanna Magni; Alessandro Morabito
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.
BMC cancer 2008;8():252.
2008: Gabriella Ferrandina; Vanda Salutari; Marco Petrillo; Arnaldo Carbone; Giovanni Scambia
Conservatively treated glassy cell carcinoma of the cervix.
World journal of surgical oncology 2008;6():92.
2008: Gabriella Ferrandina; Gabriella Macchia; Francesco Legge; Francesco Deodato; Franca Forni; Cinzia Digesù; Vito Carone; Alessio Giuseppe Morganti; Giovanni Scambia
Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Oncology 2008;74(1-2):42-9.
2008: Alessandra Battaglia; Alexia Buzzonetti; Giovanni Monego; Laura Peri; Gabriella Ferrandina; Francesco Fanfani; Giovanni Scambia; Andrea Fattorossi
Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer.
Immunology 2008;123(1):129-38.
2008: Gabriella Ferrandina; Francesco Fanfani; Manuela Ludovisi; Anna Fagotti; Arnaldo Carbone; Gian Franco Zannoni; Massimiliano Guerriero; Marco Petrillo; Giovanni Scambia
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Gynecologic oncology 2008;108(1):220-5.
2007: Franca Forni; Gabriella Ferrandina; Francesco Deodato; Gabriella Macchia; Alessio Giuseppe Morganti; Daniela Smaniotto; Stefano Luzi; Giuseppe D'Agostino; Vincenzo Valentini; Numa Cellini; Bruno Giardina; Giovanni Scambia
Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
International journal of radiation oncology, biology, physics 2007;69(4):1145-9.
2007: Gabriella Ferrandina; Francesco Legge; Anna Fagotti; Francesco Fanfani; Mariagrazia Distefano; Alessio Giuseppe Morganti; N Cellini; Giovanni Scambia
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures.
Gynecologic oncology 2007;107(1 Suppl 1):S127-32.
2007: Gabriella Ferrandina; Giovanni Scambia; Francesco Legge; Marco Petrillo; Vanda Salutari
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.
Gynecologic oncology 2007;107(1):154-6.
2007: Gabriella Ferrandina; Manuela Ludovisi; Rosa De Vincenzo; Vanda Salutari; Domenica Lorusso; M Colangelo; T Prantera; M R Valerio; Giovanni Scambia
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1348-53.
2007: Gabriella Ferrandina; Francesco Legge; Valentina Mey; Sara Nannizzi; Simona Ricciardi; Marco Petrillo; Giacomo Corrado; Giovanni Scambia
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge.
Cancer chemotherapy and pharmacology 2007;60(3):459-61.
2007: Sandro Pignata; Giovanni Scambia; Claudio Pisano; Enrico Breda; Massimo Di Maio; Stefano Greggi; Gabriella Ferrandina; Domenica Lorusso; V Zagonel; Antonio Febbraro; N Riva; V De Rosa; Ciro Gallo; Francesco Perrone
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
British journal of cancer 2007;96(11):1639-43.
2007: Antonia Carla Testa; Gabriella Ferrandina; Dirk Timmerman; Luca Savelli; Manuela Ludovisi; Caroline Van Holsbeke; Marinella Malaggese; Giovanni Scambia; Lil Valentin
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(5):505-11.
2007: Antonia Carla Testa; Dirk Timmerman; Caterina Exacoustos; Erika Fruscella; Caroline Van Holsbeke; D Bokor; Domenico Arduini; Giovanni Scambia; Gabriella Ferrandina
The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2007;29(5):512-6.
2007: Gabriella Ferrandina; Alessandro Perillo; Mariagrazia Distefano; Giuseppe D'Agostino; Valerio Gallotta; Luca Pierelli; Giovanni Scambia
Carboplatin-based neoadjuvant treatment with peripheral blood stem cell and growth factor support in locally advanced cervical cancer patients with bulky metastatic lymph nodes.
European journal of obstetrics, gynecology, and reproductive biology 2007;131(2):236-8.
2007: Domenica Lorusso; Gabriella Ferrandina; Francesco Fanfani; Maria Lucia Gagliardi; Giovanni Scambia
Investigational agents against platinum-resistant ovarian cancer.
Expert opinion on investigational drugs 2007;16(3):325-36.
2007: Gabriella Ferrandina; Mariagrazia Distefano; Manuela Ludovisi; Alessio Giuseppe Morganti; Daniela Smaniotto; Giuseppe D'Agostino; Francesco Fanfani; Giovanni Scambia
Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy.
Annals of surgical oncology 2007;14(3):1129-35.
2007: Francesco Legge; D Eaton; R Molife; Gabriella Ferrandina; I Judson; J de Bono; S Kaye
Participation of patients with gynecological cancer in phase I clinical trials: two years experience in a major cancer center.
Gynecologic oncology 2007;104(3):551-6.
2007: Gabriella Ferrandina; Arnaldo Carbone; Gian Franco Zannoni; Enrica Martinelli; Antonia Carla Testa; Valerio Gallotta; Maria De Ninno; Giovanni Scambia
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma.
The journal of obstetrics and gynaecology research 2007;33(1):95-9.
2007: Gabriella Ferrandina; Enrica Martinelli; Gian Franco Zannoni; Mariagrazia Distefano; Amelia Paglia; Ferlini Cristiano; Giovanni Scambia
Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
Gynecologic oncology 2007;104(2):326-30.
2007: Domenica Lorusso; Gabriella Ferrandina; L Pagano; Maria Lucia Gagliardi; Giovanni Scambia
Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery.
Oncology 2007;72(3-4):261-4.
2007: Gabriella Ferrandina; Gian Franco Zannoni; Enrica Martinelli; Valerio Gaetano Vellone; M G Prisco; Giovanni Scambia
Endometrial carcinoma recurring as carcinosarcoma: report of two cases.
Pathology, research and practice 2007;203(9):677-81.
2007: Gabriella Ferrandina; Gian Franco Zannoni; Marco Petrillo; Valerio Gaetano Vellone; Enrica Martinelli; Giovanni Scambia
Glassy cell carcinoma of the endometrium: a case report and review of the literature.
Pathology, research and practice 2007;203(4):217-20.
2006: Gabriella Ferrandina; Mariagrazia Distefano; Daniela Smaniotto; Alessio Giuseppe Morganti; Amelia Paglia; Gabriella Macchia; Barbara Corvari; Domenica Lorusso; Giovanni Scambia
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Gynecologic oncology 2006;103(2):500-5.
2006: Gabriella Ferrandina; Francesco Legge; Vanda Salutari; Amelia Paglia; Antonia Testa; Giovanni Scambia
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations.
European journal of cancer (Oxford, England : 1990) 2006;42(14):2296-302.
2006: Anna Fagotti; Gabriella Ferrandina; Francesco Fanfani; Alfredo Ercoli; Domenica Lorusso; Marco Rossi; Giovanni Scambia
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Annals of surgical oncology 2006;13(8):1156-61.
2006: Francesco Legge; Gabriella Ferrandina; Giovanni Scambia
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 7():vii46-8.
2006: Gabriella Ferrandina; Gian Franco Zannoni; Enrica Martinelli; Amelia Paglia; Valerio Gallotta; Simona Mozzetti; Giovanni Scambia; Ferlini Cristiano
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2774-9.
2006: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Vanda Salutari; Enrica Martinelli; Andrea Fattorossi; Domenica Lorusso; Gian Franco Zannoni; Valerio Gaetano Vellone; Amelia Paglia; Giovanni Scambia
Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2055-60.
2006: Grazia Graziani; Gabriella Ferrandina; Giacomo Pozzoli; Matteo Vergati; Alessia Muzi; Francesco Legge; Lucio Tentori; Giovanni Scambia; Pierluigi Navarra
Corticotropin-releasing hormone receptor-1 in human endometrial cancer.
Oncology reports 2006;15(2):375-9.
2006: Sandro Pignata; Gabriella Ferrandina; Giovanna Scarfone; Paolo Scollo; Franco Odicino; Luigi Selvaggi; Dionyssios Katsaros; Luigi Frigerio; Liliana Mereu; Fabio Ghezzi; Luigi Manzione; Rossella Lauria; Enrico Breda; Giovanna Marforio; Michela Ballardini; Alessandra Vernaglia Lombardi; Roberto Sorio; Salvatore Tumolo; Bruno Costa; Giovanna Magni; Francesco Perrone; Giuseppe Favalli
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study.
Oncology 2006;71(5-6):320-6.
2006: Gabriella Ferrandina; Franco O Ranelletti; Enrica Martinelli; Amelia Paglia; Gian Franco Zannoni; Giovanni Scambia
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer.
BMC cancer 2006;6():182.
2006: Gabriella Ferrandina; Vanda Salutari; Antonia Testa; Gian Franco Zannoni; Marco Petrillo; Giovanni Scambia
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: a case report and review of the literature.
BMC cancer 2006;6():169.
2006: Antonia Carla Testa; Manuela Ludovisi; Luca Savelli; Erika Fruscella; Tullio Ghi; Anna Fagotti; Giovanni Scambia; Gabriella Ferrandina
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2006;27(1):65-70.
2005: Antonia Carla Testa; Erika Fruscella; Manuela Ludovisi; Rosa De Vincenzo; Marinella Malaggese; Giacomo Corrado; Danila Basso; Giovanni Scambia; Gabriella Ferrandina
The role of sonographic examination in the follow-up of gynecological neoplasms.
Gynecologic oncology 2005;99(3):696-703.
2005: Domenica Lorusso; Gabriella Ferrandina; Erika Fruscella; L Marini; V Adamo; Giovanni Scambia
Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(6):1002-13.
2005: Erika Fruscella; Antonia Carla Testa; Gabriella Ferrandina; Frank De Smet; Caroline Van Holsbeke; Giovanni Scambia; Gian Franco Zannoni; Manuela Ludovisi; R Achten; Frederic Amant; Ignace Vergote; Dirk Timmerman
Ultrasound features of different histopathological subtypes of borderline ovarian tumors.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2005;26(6):644-50.
2005: Gabriella Ferrandina; Mariagrazia Distefano; Manuela Ludovisi; Anna Fagotti; Francesco Fanfani; Giovanni Scambia
Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma.
Gynecologic oncology 2005;99(1):246-7.
2005: Francesco Fanfani; Anna Fagotti; Gabriella Ferrandina; Giuseppe Bifulco; Francesco Legge; Domenica Lorusso; Luca Minelli; Giovanni Scambia
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis.
Human reproduction (Oxford, England) 2005;20(10):2964-8.
2005: Gabriella Ferrandina; Gian Franco Zannoni; Valerio Gallotta; E Foti; S Mancuso; Giovanni Scambia
Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report.
Gynecologic oncology 2005;99(1):215-7.
2005: Antonia Carla Testa; Gabriella Ferrandina; Erika Fruscella; Caroline Van Holsbeke; Enrico Ferrazzi; Francesco P G Leone; Domenico Arduini; Caterina Exacoustos; Daniela Bokor; Giovanni Scambia; Dirk Timmerman
The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2005;24(9):1267-78.
2005: Gabriella Ferrandina; Franco O Ranelletti; Valerio Gallotta; Enrica Martinelli; Gian Franco Zannoni; Marco Gessi; Giovanni Scambia
Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Gynecologic oncology 2005;98(3):383-9.
2005: Gabriella Ferrandina; Ida Paris; Manuela Ludovisi; Giuseppe D'Agostino; Antonia Testa; Domenica Lorusso; Mariangela Zanghi; Salvatore Pisconti; Giuseppa Pezzella; Vincenzo Adamo; Enrico Breda; Giovanni Scambia
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.
Gynecologic oncology 2005;98(2):267-73.
2005: Gabriella Ferrandina; Antonia Carla Testa; Gian Franco Zannoni; Antonella Poerio; Giovanni Scambia
Skull metastasis in primary vulvar adenocarcinoma of the Bartholin's gland: a case report.
Gynecologic oncology 2005;98(2):322-4.
2005: Gabriella Ferrandina; Domenica Lorusso; R Longo; Antonia Carla Testa; G Scambia
Pegylated liposomal doxorubicin in platinum-treated recurrent or metastatic cervical carcinoma.
Gynecologic oncology 2005;98(2):332-3.
2005: Daniela Smaniotto; Giuseppe D'Agostino; Stefano Luzi; Vincenzo Valentini; Gabriella Macchia; Giovanna Mantini; Pasquale Alessandro Margariti; Gabriella Ferrandina; Giovanni Scambia
Concurrent 5-fluorouracil, mitomycin C and radiation with or without brachytherapy in recurrent cervical cancer: a scoring system to predict clinical response and outcome.
Tumori 2005;91(4):295-301.
2005: Antonia Carla Testa; Silvia Ajossa; Gabriella Ferrandina; Erika Fruscella; Manuela Ludovisi; Marinella Malaggese; Giovanni Scambia; G B Melis; Stefano Guerriero
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2005;26(1):67-72.
2005: Giacomo Corrado; Alfredo Ercoli; Gabriella Ferrandina; Giovanni Scambia
Re: A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment by P. Morice et al.
Gynecologic oncology 2005;98(1):175; author reply 176.
2005: Daniela Smaniotto; Giuseppe D'Agostino; Stefano Luzi; Vincenzo Valentini; Gabriella Macchia; Maria Grazia Mangiacotti; Pasquale Alessandro Margariti; Gabriella Ferrandina; Giovanni Scambia
Concurrent 5-fluorouracil, mitomycin C and radiation, with or without brachytherapy, in recurrent endometrial cancer: a scoring system to predict clinical response and outcome.
Tumori 2005;91(3):215-20.
2005: Francesco Legge; Gabriella Ferrandina; Vanda Salutari; Giovanni Scambia
Biological characterization of ovarian cancer: prognostic and therapeutic implications.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv95-101.
2005: Gabriella Ferrandina; Mariagrazia Distefano; Antonia Testa; Rosa De Vincenzo; Giovanni Scambia
Management of an advanced ovarian cancer at 15 weeks of gestation: case report and literature review.
Gynecologic oncology 2005;97(2):693-6.
2005: Alessandro Perillo; Gabriella Ferrandina; Luca Pierelli; Giuseppina Bonanno; Giovanni Scambia; Salvatore Mancuso
Stem cell-based treatments for gynecological solid tumors.
European review for medical and pharmacological sciences 2005;9(2):93-102.
2005: Alfredo Ercoli; Gabriella Ferrandina; Maurizio Genuardi; Gian Franco Zannoni; Lucia Cicchillitti; Giuseppina Raspaglio; Stefania Carrara; Salvatore Mancuso; Giovanni Scambia
Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(2):308-11.
2005: Gabriella Ferrandina; Francesco Legge; Enrica Martinelli; Franco O Ranelletti; Gian Franco Zannoni; Libero Lauriola; Marco Gessi; Valerio Gallotta; Giovanni Scambia
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.
British journal of cancer 2005;92(2):271-7.
2005: Simona Mozzetti; Ferlini Cristiano; Paola Concolino; Flavia Filippetti; Giuseppina Raspaglio; Silvia Prislei; Daniela Gallo; Enrica Martinelli; Franco O Ranelletti; Gabriella Ferrandina; Giovanni Scambia
Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):298-305.
2004: Domenica Lorusso; Gabriella Ferrandina; R Lo Voi; Anna Fagotti; Giovanni Scambia
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer.
Journal of chemotherapy (Florence, Italy) 2004;16 Suppl 4():98-103.
2004: Erika Fruscella; Antonia Carla Testa; Gabriella Ferrandina; R Manfredi; Gian Franco Zannoni; Manuela Ludovisi; Marinella Malaggese; Giovanni Scambia
Sonographic features of decidualized ovarian endometriosis suspicious for malignancy.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2004;24(5):578-80.
2004: Gabriella Ferrandina; Gian Franco Zannoni; Franco O Ranelletti; Francesco Legge; Marco Gessi; Vanda Salutari; Valerio Gallotta; Libero Lauriola; Giovanni Scambia
Cyclooxygenase-2 expression in borderline ovarian tumors.
Gynecologic oncology 2004;95(1):46-51.
2004: Alessandro Perillo; Gabriella Ferrandina; Luca Pierelli; Sergio Rutella; S Mancuso; G Scambia
Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO.
Bone marrow transplantation 2004;34(8):743-4.
2004: Antonia Carla Testa; Gabriella Ferrandina; M Distefano; Erika Fruscella; Donata Mansueto; D Basso; Vanda Salutari; Giovanni Scambia
Color Doppler velocimetry and three-dimensional color power angiography of cervical carcinoma.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2004;24(4):445-52.
2004: Gian Franco Zannoni; Valerio Gallotta; Francesco Legge; Elisabetta Tarquini; Giovanni Scambia; Gabriella Ferrandina
Pseudo-Meigs' syndrome associated with malignant struma ovarii: a case report.
Gynecologic oncology 2004;94(1):226-8.
2004: Antonia Carla Testa; Donata Mansueto; Domenica Lorusso; Erika Fruscella; Danila Basso; Giovanni Scambia; Gabriella Ferrandina
Angiographic power 3-dimensional quantitative analysis in gynecologic solid tumors: feasibility and reproducibility.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2004;23(6):821-8.
2004: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Marco Gessi; Vanda Salutari; Mariagrazia Distefano; Libero Lauriola; Gian Franco Zannoni; Enrica Martinelli; Giovanni Scambia
Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3117-23.
2004: Luca Savelli; Antonia Carla Testa; Gabriella Ferrandina; Pierandrea De Iaco; Federica Rosati; Tullio Ghi; Danila Basso; Giovanni Scambia
Pelvic relapses of uterine neoplasms: transvaginal sonographic and Doppler features.
Gynecologic oncology 2004;93(2):441-5.
2004: Andrea Fattorossi; Alessandra Battaglia; Gabriella Ferrandina; Ferdinando Coronetta; Francesco Legge; Vanda Salutari; Giovanni Scambia
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
Cancer 2004;100(7):1418-28.
2004: Gabriella Ferrandina; Franco O Ranelletti; Vanda Salutari; Marco Gessi; Francesco Legge; Gian Franco Zannoni; Giovanni Scambia; Libero Lauriola
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Gynecologic oncology 2004;92(2):537-44.
2004: Anna Fagotti; Gabriella Ferrandina; Francesco Fanfani; Francesco Legge; Libero Lauriola; Marco Gessi; Paola Castelli; Fabrizio Barbieri; Luca Minelli; Giovanni Scambia
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters.
Human reproduction (Oxford, England) 2004;19(2):393-7.
2004: Domenica Lorusso; A Naldini; A Testa; Giuseppe D'Agostino; Giovanni Scambia; Gabriella Ferrandina
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?
Oncology 2004;67(3-4):243-9.
2004: Mariagrazia Distefano; Gabriella Ferrandina; Daniela Smaniotto; Alessandro Pasquale Margariti; Gian Franco Zannoni; Gabriella Macchia; Riccardo Manfredi; Maria Grazia Mangiacotti; Numa Cellini; Giovanni Scambia
Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
Oncology 2004;67(2):103-11.
2004: Andrea Fattorossi; Alessandra Battaglia; Gabriella Ferrandina; Alexia Buzzonetti; Francesco Legge; Vanda Salutari; Giovanni Scambia
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients.
Gynecologic oncology 2004;92(1):106-15.
2003: Alessandra Battaglia; Gabriella Ferrandina; Alexia Buzzonetti; Paolo Malinconico; Francesco Legge; Vanda Salutari; Giovanni Scambia; Andrea Fattorossi
Lymphocyte populations in human lymph nodes. Alterations in CD4+ CD25+ T regulatory cell phenotype and T-cell receptor Vbeta repertoire.
Immunology 2003;110(3):304-12.
2003: Gabriella Ferrandina; Franco O Ranelletti; Libero Lauriola; Gian Franco Zannoni; Francesco Legge; Marco Gessi; Vanda Salutari; Giovanni Scambia
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.
Oncology reports 2003;10(6):1799-804.
2003: G D'Agostino; Gabriella Ferrandina; Manuela Ludovisi; A Testa; Domenica Lorusso; N Gbaguidi; Enrico Breda; Salvatore Mancuso; Giovanni Scambia
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.
British journal of cancer 2003;89(7):1180-4.
2003: Erika Fruscella; Daniela Gallo; Gabriella Ferrandina; Giuseppe D'Agostino; Giovanni Scambia
Gemcitabine: current role and future options in the treatment of ovarian cancer.
Critical reviews in oncology/hematology 2003;48(1):81-8.
2003: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Libero Lauriola; Vanda Salutari; Marco Gessi; Antonia Carla Testa; Ulrike Werner; Pierluigi Navarra; Giuseppe Tringali; Alessandra Battaglia; Giovanni Scambia
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4324-31.
2003: Domenica Lorusso; Gabriella Ferrandina; Stefano Greggi; Angiolo Gadducci; Sandro Pignata; S Tateo; Rosalbino Biamonte; Luigi Manzione; Giovanni Di Vagno; F Ferrau'; Giovanni Scambia
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1086-93.
2003: Ferlini Cristiano; Giuseppina Raspaglio; Simona Mozzetti; Mariagrazia Distefano; Flavia Filippetti; Enrica Martinelli; Gabriella Ferrandina; Daniela Gallo; Franco O Ranelletti; Giovanni Scambia
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance.
Molecular pharmacology 2003;64(1):51-8.
2003: Elisabetta Marana; Giovanni Scambia; Maria Lodovica Maussier; Raffaella Parpaglioni; Gabriella Ferrandina; Francesco Meo; Mario Sciarra; Riccardo Marana
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy.
The Journal of the American Association of Gynecologic Laparoscopists 2003;10(2):159-65.
2003: Alfredo Ercoli; Anna Fagotti; Mario Malzoni; Gabriella Ferrandina; T Susini; C Malzoni; Giovanni Scambia
Radiofrequency bipolar coagulation for radical hysterectomy: technique, feasibility and complications.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(2):187-91.
2003: Antonia Carla Testa; Mario Ciampelli; Carmen Mastromarino; Rossella Lopez; Gian Franco Zannoni; Gabriella Ferrandina; Giovanni Scambia
Intratumoral color Doppler analysis in endometrial carcinoma: is it clinically useful?
Gynecologic oncology 2003;88(3):298-303.
2003: Francesco Fanfani; Gabriella Ferrandina; Giacomo Corrado; Anna Fagotti; Haim Vito Zakut; Salvatore Mancuso; Giovanni Scambia
Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients.
Oncology 2003;65(4):316-22.
2003: Giuseppina Raspaglio; Gabriella Ferrandina; Ferlini Cristiano; Giovanni Scambia; Franco O Ranelletti
Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects.
Oncology research 2003;14(2):83-91.
2003: Antonia Carla Testa; Francesco Pomini; Andrea Fattorossi; Alessandra Battaglia; Gabriella Ferrandina; Donata Mansueto; Carmen Mastromarino; Giovanni Scambia; Alessandro Caruso
Doppler velocimetry and cytofluorimetric analysis in uterine myomas.
Gynecologic and obstetric investigation 2003;56(3):139-42.
2003: Gabriella Ferrandina; Luca Pierelli; Alessandro Perillo; Sergio Rutella; Manuela Ludovisi; Giuseppe Leone; Salvatore Mancuso; Giovanni Scambia
Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):195-200.
2003: Gabriella Ferrandina; Franco O Ranelletti; Francesco Legge; Libero Lauriola; Antonella Poerio; Gian Franco Zannoni; Daniela Smaniotto; Pasquale Alessandro Margariti; Gabriella Macchia; Giovanni Scambia
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery.
International journal of radiation oncology, biology, physics 2003;55(1):21-7.
2002: Daniela Gallo; Gabriella Ferrandina; Sabrina Giacomelli; Erika Fruscella; Gian Franco Zannoni; Paolo Morazzoni; Antonella Riva; Ezio Bombardelli; Salvatore Mancuso; Giovanni Scambia
Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumors.
Cancer letters 2002;186(1):43-8.
2002: Gabriella Ferrandina; Libero Lauriola; Gian Franco Zannoni; Mariagrazia Distefano; Francesco Legge; Vanda Salutari; Marco Gessi; Nicola Maggiano; Giovanni Scambia; Franco O Ranelletti
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications.
British journal of cancer 2002;87(10):1145-52.
2002: Gabriella Ferrandina; Francesco Legge; Franco O Ranelletti; Gian Franco Zannoni; Nicola Maggiano; Antonella Evangelisti; Salvatore Mancuso; Giovanni Scambia; Libero Lauriola
Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome.
Cancer 2002;95(4):801-7.
2002: Gabriella Ferrandina; Libero Lauriola; Gian Franco Zannoni; Anna Fagotti; Francesco Fanfani; Francesco Legge; Nicola Maggiano; Marco Gessi; S Mancuso; Franco O Ranelletti; Giovanni Scambia
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1205-11.
2002: Anna Fagotti; Gabriella Ferrandina; Romina Longo; Salvatore Mancuso; Giovanni Scambia
Minilaparotomy in early stage endometrial cancer: an alternative to standard and laparoscopic treatment.
Gynecologic oncology 2002;86(2):177-83.
2002: Marcello Ceccaroni; Giuseppe D'Agostino; Gabriella Ferrandina; Angiolo Gadducci; Giovanni Di Vagno; Sandro Pignata; Antonella Poerio; Maria Giovanna Salerno; Antonio Fanucchi; Maria Teresa Lapresa; Rosa Tambaro; Giovanni Scambia
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study.
Gynecologic oncology 2002;85(3):445-50.
2002: Gabriella Ferrandina; Franco O Ranelletti; Libero Lauriola; Francesco Fanfani; Francesco Legge; M Mottolese; M R Nicotra; P G Natali; V H Zakut; Giovanni Scambia
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer.
Gynecologic oncology 2002;85(2):305-10.
2002: Giuseppe D'Agostino; Mariagrazia Distefano; Stefano Greggi; MariaGiovanna Salerno; Gabriella Ferrandina; Antonella Poerio; Salvatore Mancuso; Giovanni Scambia
Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
Cancer chemotherapy and pharmacology 2002;49(3):256-60.
2002: Gabriella Ferrandina; Libero Lauriola; Mariagrazia Distefano; Gian Franco Zannoni; Marco Gessi; Francesco Legge; Nicola Maggiano; Salvatore Mancuso; A Capelli; Giovanni Scambia; Franco O Ranelletti
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):973-81.
2002: Giuseppe D'Agostino; Gabriella Ferrandina; Giorgia Garganese; M Giovanna Salerno; Domenica Lorusso; M Giuseppina Farnetano; Salvatore Mancuso; Giovanni Scambia
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.
Oncology 2002;62(2):110-4.
2001: Raffaella Giannice; T Susini; Gabriella Ferrandina; Antonella Poerio; Pasquale Alessandro Margariti; R Carminati; E Marana; Salvatore Mancuso; Giovanni Scambia
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients.
Cancer 2001;92(10):2562-8.
2001: Giovanni Scambia; Gabriella Ferrandina; Mariagrazia Distefano; Anna Fagotti; R Manfredi; Gian Franco Zannoni; Salvatore Mancuso
Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
Gynecologic oncology 2001;83(2):319-24.
2001: Daniela Gallo; Sabrina Giacomelli; F Cantelmo; Gian Franco Zannoni; Gabriella Ferrandina; Erika Fruscella; Antonella Riva; Paolo Morazzoni; Ezio Bombardelli; Salvatore Mancuso; Giovanni Scambia
Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy.
Breast cancer research and treatment 2001;69(2):153-64.
2001: Guillherme Cantuaria; A Fagotti; Gabriella Ferrandina; A Magalhaes; Mehrdad Nadji; Roberto Angioli; Manuel Penalver; Salvatore Mancuso; Giovanni Scambia
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy.
Cancer 2001;92(5):1144-50.
2001: Gabriella Ferrandina; Franco O Ranelletti; L M Larocca; Nicola Maggiano; Erika Fruscella; Francesco Legge; Giuseppe Santeusanio; Alessandro Bombonati; Salvatore Mancuso; Giovanni Scambia
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2656-61.
2001: MG Salerno; Gabriella Ferrandina; Stefano Greggi; Luca Pierelli; G Menichella; G Leone; Giovanni Scambia; Salvatore Mancuso
High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.
Bone marrow transplantation 2001;27(10):1017-25.
2001: S Fiumicino; Alfredo Ercoli; Gabriella Ferrandina; P Hess; Giuseppina Raspaglio; Maurizio Genuardi; Valentina Rovella; A Bellacosa; Lucia Cicchillitti; Salvatore Mancuso; Margherita Bignami; Giovanni Scambia
Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1008-14.
2001: Andrea Fattorossi; Alessandra Battaglia; Luca Pierelli; Paolo Malinconico; Leila Andreocci; Alessandro Perillo; Gabriella Ferrandina; Olga Martelli; Aurelia Rughetti; Marianna Nuti; E Cortesi; Giovanni Scambia
Effects of granulocyte-colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor administration on T cell proliferation and phagocyte cell-surface molecules during hematopoietic reconstitution after autologous peripheral blood progenitor cell transplantation.
Cancer immunology, immunotherapy : CII 2001;49(12):641-8.
2001: Stefano Greggi; M G Salerno; Giuseppe D'Agostino; Gabriella Ferrandina; Domenica Lorusso; Luigi Manzione; Salvatore Mancuso; Giovanni Scambia
Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer.
Oncology 2001;60(1):19-23.
2000: C Lavarino; Silvana Pilotti; Maria Oggionni; Laura Gatti; Paola Perego; G Bresciani; Marco A Pierotti; G Scambia; Gabriella Ferrandina; Anna Fagotti; Costantino Mangioni; V Lucchini; F Vecchione; Giorgio Bolis; Giovanna Scarfone; Franco Zunino
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3936-45.
2000: Gabriella Ferrandina; A Stoler; Anna Fagotti; Francesco Fanfani; R Sacco; A De Pasqua; Salvatore Mancuso; Giovanni Scambia
p21WAF1/CIP1 protein expression in primary ovarian cancer.
International journal of oncology 2000;17(6):1231-5.
2000: Gabriella Ferrandina; Simona Mozzetti; Maria Marone; A Fagotti; Gabriella Macchia; Salvatore Mancuso; Giovanni Scambia
Bcl-2, bax, bcl-x(L) and bcl-x(S) expression in neoplastic and normal cervical tissue.
Cancer letters 2000;155(1):19-27.
2000: Maria Marone; Gabriella Ferrandina; Gabriella Macchia; Simona Mozzetti; A De Pasqua; Pierluigi Benedetti Panici; Salvatore Mancuso; Giovanni Scambia
Bcl-2, Bax, Bcl-x(L) and Bcl-x(S) expression in neoplastic and normal endometrium.
Oncology 2000;58(2):161-8.
2000: Gabriella Ferrandina; P Filippini; Ferlini Cristiano; Nicola Maggiano; A B Stoler; Erika Fruscella; Simona Mozzetti; Salvatore Mancuso; R S Freedman; Giovanni Scambia; Franco O Ranelletti
Growth inhibitory effects and radiosensitization induced by fatty aromatic acids on human cervical cancer cells.
Oncology research 2000;12(9-10):429-40.
2000: Simona Mozzetti; Gabriella Ferrandina; Maria Marone; F D'Ingiullo; Erika Fruscella; A De Pasqua; Salvatore Mancuso; Giovanni Scambia
Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Cancer detection and prevention 2000;24(6):536-41.
1999: Gabriella Ferrandina; Anna Fagotti; MG Salerno; P G Natali; M Mottolese; F Maneschi; A De Pasqua; Pierluigi Benedetti Panici; Salvatore Mancuso; Giovanni Scambia
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer.
British journal of cancer 1999;81(4):733-40.
1999: E Foti; Gabriella Ferrandina; R Martucci; M E Romanini; Pierluigi Benedetti Panici; Ugo Testa; Salvatore Mancuso; Giovanni Scambia
IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels.
Oncology 1999;57(3):211-5.
1999: Alfredo Ercoli; Gabriella Ferrandina; Giuseppina Raspaglio; Maria Marone; N Maggiano; P Del Mastro; Pierluigi Benedetti Panici; Salvatore Mancuso; Giovanni Scambia
hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer.
British journal of cancer 1999;80(10):1665-71.
1999: Ferlini Cristiano; Giovanni Scambia; Maria Marone; Mariagrazia Distefano; C Gaggini; Gabriella Ferrandina; Andrea Fattorossi; G Isola; Pierluigi Benedetti Panici; Salvatore Mancuso
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines.
British journal of cancer 1999;79(2):257-63.
1998: Maria Marone; Giovanni Scambia; Simona Mozzetti; Gabriella Ferrandina; S Iacovella; A De Pasqua; Pierluigi Benedetti Panici; Salvatore Mancuso
bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):517-24.
1998: Giovanni Scambia; Gabriella Ferrandina; M Distefano; G D'Agostino; Pierluigi Benedetti Panici; Salvatore Mancuso
Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer.
Cancer letters 1998;123(2):135-9.
1998: Maria Marone; Giovanni Scambia; C Giannitelli; Gabriella Ferrandina; Valeria Masciullo; Alfonso Bellacosa; Pierluigi Benedetti Panici; Salvatore Mancuso
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.
International journal of cancer. Journal international du cancer 1998;75(1):34-9.
1997: Valeria Masciullo; G Scambia; Maria Marone; C Giannitelli; Gabriella Ferrandina; Alfonso Bellacosa; Pierluigi Benedetti Panici; S Mancuso
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.
International journal of cancer. Journal international du cancer 1997;74(4):390-5.
1997: Gabriella Ferrandina; Giovanni Scambia; G Damia; G Tagliabue; Anna Fagotti; Pierluigi Benedetti Panici; Costantino Mangioni; S Mancuso; M D'Incalci
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):343-50.
1997: Giovanni Scambia; Valeria Masciullo; Pierluigi Benedetti Panici; Maria Marone; Gabriella Ferrandina; N Todaro; A Bellacosa; S K Jain; G Neri; A Piffanelli; Salvatore Mancuso
Prognostic significance of ras/p21 alterations in human ovarian cancer.
British journal of cancer 1997;75(10):1547-53.
1996: Giovanni Scambia; E Foti; Gabriella Ferrandina; F P Leone; A Gadducci; Pierluigi Benedetti Panici; Salvatore Mancuso
Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer.
American journal of obstetrics and gynecology 1996;175(6):1606-10.
1996: M Maurizi; Giovanni Almadori; Gabriella Ferrandina; Mariagrazia Distefano; M E Romanini; Gabriella Cadoni; Pierluigi Benedetti Panici; Gaetano Paludetti; Giovanni Scambia; Salvatore Mancuso
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.
British journal of cancer 1996;74(8):1253-7.
1996: Maria Marone; Giovanni Scambia; Gabriella Ferrandina; C Giannitelli; Pierluigi Benedetti Panici; S Iacovella; A Leone; Salvatore Mancuso
Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.
British journal of cancer 1996;74(7):1063-8.
1996: Giovanni Scambia; Rosa I De Vincenzo; Franco O Ranelletti; P B Panici; Gabriella Ferrandina; G D'Agostino; A Fattorossi; E Bombardelli; Salvatore Mancuso
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):877-82.
1996: Gabriella Ferrandina; Giovanni Scambia; Maria Marone; Pierluigi Benedetti Panici; C Giannitelli; S Pernisco; F Coronetta; Salvatore Mancuso
NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
Annals of the New York Academy of Sciences 1996;784():509-12.
1996: Giovanni Scambia; Pierluigi Benedetti Panici; Gabriella Ferrandina; Mariagrazia Distefano; G Salerno; M E Romanini; G d'Agostino; Anna Fagotti; Salvatore Mancuso
Prognostic significance of receptors for epidermal growth factor, estrogen, and progesterone in ovarian cancer.
Annals of the New York Academy of Sciences 1996;784():202-8.
1996: M Maurizi; Giovanni Almadori; Gabriella Cadoni; Giovanni Scambia; fabrizio ottaviani; Gabriella Ferrandina; Gaetano Paludetti; G D'Abramo; Salvatore Mancuso
Cathepsin D concentration in primary laryngeal cancer: correlation with clinico-pathological parameters, EGFR status and prognosis.
International journal of cancer. Journal international du cancer 1996;69(2):105-9.
1996: Giovanni Scambia; E Foti; Gabriella Ferrandina; F P Leone; M Marciano; Salvatore Mancuso
Multiple tumour marker assays in advanced cervical cancer: relationship to chemotherapy response and clinical outcome.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):259-63.
1996: Giovanni Scambia; Gabriella Ferrandina; Maria Marone; Pierluigi Benedetti Panici; C Giannitelli; M Piantelli; A Leone; Salvatore Mancuso
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):334-42.
1996: Alfonso Bellacosa; Giovanni Almadori; S Cavallo; Gabriella Cadoni; Jacopo Galli; Gabriella Ferrandina; G Scambia; G Neri
Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):175-80.
1995: Franco O Ranelletti; Giovanni Scambia; Pierluigi Benedetti Panici; Mauro Piantelli; Gabriella Ferrandina; G D'Agostino; Rosa I De Vincenzo; Alessandro Rinelli; G Isola; Salvatore Mancuso
Methyl-p-hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parameters.
International journal of cancer. Journal international du cancer 1995;62(5):536-41.
1995: Gabriella Ferrandina; Franco O Ranelletti; Giovanni Scambia; Pierluigi Benedetti Panici; G D'Agostino; Mauro Piantelli; G Isola; Salvatore Mancuso
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS).
Cancer letters 1995;96(1):123-31.
1995: Alfonso Bellacosa; D de Feo; A K Godwin; DW Bell; Jin Q Cheng; Deborah A Altomare; M Wan; Louis Dubeau; Giovanni Scambia; Valeria Masciullo; Gabriella Ferrandina; Pierluigi Benedetti Panici; Salvatore Mancuso; Giovanni Neri; Joseph R Testa
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
International journal of cancer. Journal international du cancer 1995;64(4):280-5.
1995: Giovanni Scambia; Pierluigi Benedetti Panici; Gabriella Ferrandina; Mariagrazia Distefano; G Salerno; M E Romanini; Anna Fagotti; Salvatore Mancuso
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy.
British journal of cancer 1995;72(2):361-6.
1995: Giovanni Scambia; Pierluigi Benedetti Panici; Gabriella Ferrandina; Mariagrazia Distefano; M E Romanini; G Sica; Salvatore Mancuso
Significance of cathepsin-D expression in uterine tumours.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1449-54.
1994: Giovanni Scambia; Pierluigi Benedetti Panici; E Foti; M Amoroso; G Salerno; Gabriella Ferrandina; Francesco Battaglia; Stefano Greggi; A De Gaetano; G Puglia
Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2309-16.
1994: Giovanni Scambia; P B Panici; Gabriella Ferrandina; Francesco Battaglia; G Sica; F Coronetta; C Rumi; Salvatore Mancuso
Effect of recombinant human interferon-alpha/2b on epidermal-growth-factor-, estrogen- and progesterone-receptor expression in primary cervical cancer.
International journal of cancer. Journal international du cancer 1994;58(6):769-73.
1994: Giovanni Scambia; A Gadducci; P B Panici; E Foti; M Ferdeghini; Gabriella Ferrandina; M Amoroso; C Castellani; V Facchini; Salvatore Mancuso
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma.
Gynecologic oncology 1994;54(3):292-7.
1994: Giovanni Scambia; L Catozzi; Pierluigi Benedetti Panici; Gabriella Ferrandina; Giovanni Almadori; Gaetano Paludetti; Gabriella Cadoni; Mariagrazia Distefano; Adriano Piffanelli; Salvatore Mancuso
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors.
British journal of cancer 1994;69(6):995-9.
1994: Francesco Battaglia; Giovanni Scambia; P B Panici; M Castelli; Gabriella Ferrandina; E Foti; M Amoroso; G D'Andrea; Salvatore Mancuso
Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen (SCC) in patients with cervical cancer.
Gynecologic oncology 1994;53(2):176-82.
1994: Giovanni Scambia; P B Panici; Franco O Ranelletti; Gabriella Ferrandina; Rosa I De Vincenzo; Mauro Piantelli; Valeria Masciullo; G Bonanno; G Isola; Salvatore Mancuso
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cells.
International journal of cancer. Journal international du cancer 1994;57(2):211-5.
1994: Giovanni Scambia; Pierluigi Benedetti Panici; Gabriella Ferrandina; Francesco Battaglia; Mariagrazia Distefano; G D'Andrea; Rosa I De Vincenzo; F Maneschi; Franco O Ranelletti; S Mancuso
Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
International journal of cancer. Journal international du cancer 1994;56(1):26-30.
1994: Giovanni Scambia; P B Panici; Gabriella Ferrandina; G Salerno; G D'Agostino; Mariagrazia Distefano; Rosa I De Vincenzo; Alfredo Ercoli; Salvatore Mancuso
Clinical significance of cathepsin D in primary ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):935-40.
1994: Giovanni Scambia; Franco O Ranelletti; P B Panici; Rosa I De Vincenzo; G Bonanno; Gabriella Ferrandina; Mauro Piantelli; S Bussa; C Rumi; M Cianfriglia
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.
Cancer chemotherapy and pharmacology 1994;34(6):459-64.
1993: Giovanni Scambia; L Catozzi; Pierluigi Benedetti Panici; Gabriella Ferrandina; Francesco Battaglia; G Giovannini; Mariagrazia Distefano; D Pellizzola; A Piffanelli; S Mancuso
Expression of ras p21 oncoprotein in normal and neoplastic human endometrium.
Gynecologic oncology 1993;50(3):339-46.
1993: Giovanni Scambia; Franco O Ranelletti; P B Panici; Mauro Piantelli; Rosa I De Vincenzo; Gabriella Ferrandina; G Bonanno; A Capelli; Salvatore Mancuso
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines.
International journal of cancer. Journal international du cancer 1993;54(3):462-6.
1993: Gabriella Ferrandina; Giovanni Scambia; Pierluigi Benedetti Panici; Franco O Ranelletti; Rosa I De Vincenzo; Mauro Piantelli; Mariagrazia Distefano; A Capelli; Salvatore Mancuso
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor.
Gynecologic oncology 1993;49(1):67-72.
1993: Giovanni Scambia; L Catozzi; P B Panici; Gabriella Ferrandina; F Coronetta; R Barozzi; G Baiocchi; Licia Uccelli; A Piffanelli; Salvatore Mancuso
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.
American journal of obstetrics and gynecology 1993;168(1 Pt 1):71-8.
1992: Gabriella Ferrandina; Giovanni Scambia; Pierluigi Benedetti Panici; Giovanni Almadori; Gaetano Paludetti; Gabriella Cadoni; Mariagrazia Distefano; M Maurizi; Salvatore Mancuso
Cathepsin D in primary squamous laryngeal tumors: correlation with clinico-pathological parameters and receptor status.
Cancer letters 1992;67(2-3):133-8.
1992: M Maurizi; Giovanni Scambia; Pierluigi Benedetti Panici; Gabriella Ferrandina; Giovanni Almadori; Gaetano Paludetti; Rosa I De Vincenzo; Mariagrazia Distefano; D Brinchi; Gabriella Cadoni
EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significance.
International journal of cancer. Journal international du cancer 1992;52(6):862-6.
1992: Giovanni Scambia; Franco O Ranelletti; Pierluigi Benedetti Panici; Mauro Piantelli; G Bonanno; Rosa I De Vincenzo; Gabriella Ferrandina; N Maggiano; A Capelli; S Mancuso
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II).
Gynecologic oncology 1992;45(1):13-9.
1992: Giovanni Scambia; Pierluigi Benedetti Panici; Francesco Battaglia; Gabriella Ferrandina; G Baiocchi; Stefano Greggi; Rosa I De Vincenzo; Salvatore Mancuso
Significance of epidermal growth factor receptor in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):529-35.
1992: Gabriella Ferrandina; Giovanni Scambia; P Benedetti Panici; G Bonanno; Rosa I De Vincenzo; Carlo Rumi; S Bussa; M Genuardi; vincenzo romano spica; V Spica Romano; Salvatore Mancuso
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cells.
Molecular and cellular endocrinology 1992;83(2-3):183-93.
1992: Giovanni Scambia; Franco O Ranelletti; Pierluigi Benedetti Panici; Mauro Piantelli; Rosa I De Vincenzo; G Bonanno; Gabriella Ferrandina; G Isola; Salvatore Mancuso
Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1885-9.
1991: Giovanni Scambia; Pierluigi Benedetti Panici; Gabriella Ferrandina; Francesco Battaglia; S Rossi; R Bellantone; F Crucitti; Salvatore Mancuso
Cathepsin D and epidermal growth factor in human breast cyst fluid.
British journal of cancer 1991;64(5):965-7.
1991: Giovanni Scambia; P Benedetti; Gabriella Ferrandina; Francesco Battaglia; G Baiocchi; Salvatore Mancuso
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
British journal of cancer 1991;64(1):182-4.
1991: Giovanni Scambia; P B Panici; Francesco Battaglia; Gabriella Ferrandina; G Almadori; G Paludetti; M Maurizi; Salvatore Mancuso
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors.
Cancer 1991;67(5):1347-51.
1991: Giovanni Scambia; Franco O Ranelletti; Pierluigi Benedetti Panici; Mauro Piantelli; G Bonanno; Rosa I De Vincenzo; Gabriella Ferrandina; Luca Pierelli; A Capelli; Salvatore Mancuso
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.
Cancer chemotherapy and pharmacology 1991;28(4):255-8.
1991: Giovanni Scambia; P B Panici; Francesco Battaglia; Gabriella Ferrandina; G Baiocchi; A Gallo; G Sica; Salvatore Mancuso
Effect of recombinant human interferon-alpha 2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(1):51-3.
1990: Giovanni Scambia; Franco O Ranelletti; P B Panici; Mauro Piantelli; G Bonanno; Rosa I De Vincenzo; Gabriella Ferrandina; C Rumi; L M Larocca; Salvatore Mancuso
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.
British journal of cancer 1990;62(6):942-6.
1990: Gabriella Ferrandina; Giovanni Scambia; F O Ranelletti; Pierluigi Benedetti Panici; Francesco Battaglia; Salvatore Mancuso
Morphological changes induced by epidermal growth factor and estradiol on CG5 human breast cancer cell line: a scanning electron microscopy study.
Anticancer research 1990;10(4):991-4.
1990: Giovanni Scambia; P B Panici; G Baiocchi; Francesco Battaglia; Gabriella Ferrandina; Stefano Greggi; Salvatore Mancuso
Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen.
Gynecologic oncology 1990;37(3):323-6.
1990: Giovanni Scambia; P B Panici; S Iacobelli; G Baiocchi; Francesco Battaglia; L Perrone; C Sonsini; Gabriella Ferrandina; Clara Natoli; Salvatore Mancuso
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignancies.
Cancer 1990;65(6):1325-8.
1989: Giovanni Scambia; P B Panici; Francesco Battaglia; Gabriella Ferrandina; C Gaggini; Salvatore Mancuso
Growth inhibitory effect of diheptyl diselenide on various human cancer cell lines.
Anticancer research 1989;9(6):1697-9.
1989: Francesco Battaglia; S Rossi; Giovanni Scambia; A Lanzone; Pierluigi Benedetti Panici; Gabriella Ferrandina; Celestino Pio Lombardi; R Bellantone; F Crucitti; Salvatore Mancuso
Epidermal growth factor levels in human breast cyst fluid.
Anticancer research 1989;9(6):1661-3.
1988: F Battaglia; Giovanni Scambia; Carlo Provenzano; S Rossi; Pierluigi Benedetti Panici; Gabriella Ferrandina; Emanuela Bartoccioni; F Crucitti; Salvatore Mancuso
Receptor for epidermal growth factor in neoplastic and non-neoplastic human thymus.
Annals of the New York Academy of Sciences 1988;551():366-8.